氨甲环酸治疗狄波-普维拉所致的子宫不规则出血的效果

摘要
图/表
参考文献(20)
相关文章 (15)

全文: PDF (561 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探索使用氨甲环酸治疗狄波-普维拉（DMPA）所致的子宫不规则出血（IUB）的疗效与安全性。方法选择2015年12月~2016年12月中国医科大学附属第一医院收治的80例DMPA所致IUB患者，采用块状随机法将其分为氨甲环酸5 d治疗的治疗组和安慰剂5 d治疗的安慰剂组，每组各40例。随访观察4周，通过患者汇报的IUB信息表观察患者的7 d止血例数、28 d无出血时间及不良反应发生情况。结果安慰剂组失访1例，治疗组中33例（82.5%）受试者用药后7 d内止血；安慰剂组中10例（25.6%）受试者用药7 d内止血，差异有统计学意义（P < 0.05）。治疗组受试者28 d无出血时长为（20.73±4.07）d，安慰剂组为（11.90±5.78）d，差异有统计学意义（P < 0.05）。治疗组1例患者有轻微恶心。结论氨甲环酸治疗DMPA所致的IUB疗效显著，安全性好。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张雪李天人郭毅

关键词 ：狄波-普维拉, 氨甲环酸, 疗效, 安全性

Abstract：Objective To explore the efficacy and safety of Tranexamic Acid in treating irregular uterine bleeding secondary to Depot-medroxyprogesterone acetat. Methods From December 2015 to December 2016, in First Affiliated Hospital of Chinese Medical Sciences University, 80 patients with irregular uterine bleeding secondary to Depot-medroxyprogesterone acetat treatment were recruited. According to random number table, they were divided into treatment group and placebo group with 40 cases in each group, and they were treated with Tranexamic Acid and placebo respectively. All patients were followed up for 4 weeks, the outcomes were evaluated by the number of blood termination within 7 days and 28-day bleeding-free days and side effects reports were observed by information table. Results One case of the placebo group lost during follow-up, 33 cases (82.5%) in the treatment group and 10 cases (25.6%) in the placebo group stopped bleeding within 7 days after treatment initiation, the difference was statistically significant (P < 0.01). The 28-day bleeding-free proportion in treatment group was (20.73±4.07) d, that in the placebo group was (11.90±5.78) d, the difference was statistically significant (P < 0.01). One case of mild nausea was reported. Conclusion Tranexamic Acid is an effective and safe choice in dealing with irregular uterine bleeding secondary to Depot-medroxyprogesterone acetat treatment.

Key words： Depot-medroxyprogesterone acetat Tranexamic Acid Efficacy Safety

基金资助:国家自然科学基金资助项目（81572054）。

通讯作者: 李天人（1981.12-），男，博士；研究方向：妇科肿瘤。

作者简介: 张雪（1985.11-），女，硕士；研究方向：妇科肿瘤和内分泌疾病。

引用本文:

张雪李天人郭毅. 氨甲环酸治疗狄波-普维拉所致的子宫不规则出血的效果[J]. 中国医药导报, 2017, 14(15): 121-123.
ZHANG Xue LI Tianren GUO Yi. Efficacy of Tranexamic Acid in treatment of irregular uterine bleeding caused by Depot-medroxyprogesterone acetat. 中国医药导报, 2017, 14(15): 121-123.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2017/V14/I15/121

[1] Taneepanichskul S，Reinprayoon D，Phaosavadi S. DMPA use above the age of 35 in Thai women [J]. Contraception，2000， 67（61）：281-282.
[2] Chotnopparatpattara P，Taneepanichskul S. Use of depot medroxyprogesterone acetate in Thai adolescents [J]. Contraception，2000，62：137-140.
[3] 郭冬梅，龚龑龑，汤华臻，等.产后妇女避孕节育服务需求调查[J].上海医药，2016，20（12）：58-60.
[4] Lockwood CJ，Runic R，Wan L，et al. The role of tissue factor in regulating endometrial haemostasis：implications for progestin-only contraception [J]. Hum Reprod，2000， 15（3）：144-151.
[5] Subakir SB，Abdul MO，Sabariah S，et al. Oxidative stress，vitamin E and progestin breakthrough bleeding [J]. Hum Reprod，2010，65（3）：18-23.
[6] Fraser IS，Hickey M. Endometrial vascular changes and bleeding disturbances with long-acting progestins [J]. Steroids，2010，65（4）：665-670.
[7] Adashi EY，Rock JA，Rosenwaks Z，editors. Reproductive endocrinology，surgery and technology [M]. Philadelphia：Lippincott-Raven，2016：841-858.
[8] Speroff L，Fritz MA. Clinical gynecologic endocrinology and infertility [J]. Lippincott Williams Wilkins，2005：949-969.
[9] Tantiwattanakul P，Taneepanichskul S. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users [J]. Contraception，2014，81（70）：277-279.
[10] Nathirojanakun P，Taneepanichskul S，Sappakit-Kumjorn N. Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users [J]. Contraception，2006，73（3）：584-587.
[11] Wellington K，Wagstaff AJ. Tranexamic acid：a review of its use in the management of menorrhagia [J]. Drugs，2003， 63（2）：1417-1433.
[12] Katzung BG. Basic and clinical pharmacology [M]. New York：McGraw Hill，2004：543-560.
[13] Bonnar J，Sheppard BL. Treatment of menorrhagia during menstruation：randomised controlled trial of ethamsylate，mefenamic acid，and tranexamic acid [J]. BMJ，2016，313（3）：579-582.
[14] Preston JT，Cameron IT，Adams EJ，et al. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia [J]. Br J Obstet Gynaecol，1995，102（5）：401-406.
[15] Runic R，Schatz F，Krey L，et al. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using norplant-2 contraception [J]. J Clin Endocrinol Metab，1997，82（9）：1983-1988.
[16] Phupong V，Sophonsritsuk A，Taneepanichskul S. The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use [J]. Contraception，2006， 73（5）：253-256.
[17] Ferrer P，Roberts I，Sydenham E，et al. Anti-fibrinolytica systematic review [J]. BMC Pregancy Childbirt，2009，9（29）：1532-1539.
[18] Shakur H，Elbourne D，Gülmezoglu M，et al. The WOMAN Trial（World Maternal Antifibrinolytic Trial）：tranexamic acid for the treatment of postpartum haemorrhage：an international randomised，double blind placebo controlled trial [J]. Trials，2010，10（6）：254.
[19] Shakur H，Roberts I，Edwards P，et al. The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage：statistical analysis plan for the WOMAN trial [J]. Trials，2016，17（1）：249.
[20] 王霞，汤玉兰，王琼，等.治疗月经过多的首个非激素类药物氨甲环酸缓释片的研究进展[J].中国药房，2014， 25（14）：1316-1320.